Investors

Insider Transactions

Date Name Title Type Shares Traded Price Range
Mar 5, 2013 schleifer leonard s Officer Automatic Sell 19,146 175.21
Feb 26, 2013 shooter eric m Director Acquisition (Non Open Market) 10,000 n/a
Feb 26, 2013 shooter eric m Director Sell 10,000 160.00
Jan 16, 2013 goldberg murray a Officer Automatic Sell 7,878 170.57 - 174.56
Jan 9, 2013 goldstein joseph l Director Automatic Sell 5,000 185.00
Jan 9, 2013 goldstein joseph l Director Option Execute 5,000 57.11
Jan 9, 2013 powchik peter Officer Option Execute 5,752 16.80 - 21.25
Jan 8, 2013 vagelos p roy Officer Disposition (Non Open Market) 1,254 n/a
Jan 4, 2013 goldstein joseph l Director Automatic Sell 5,000 180.50 - 181.22
Jan 4, 2013 goldstein joseph l Director Option Execute 5,000 33.42
Jan 3, 2013 powchik peter Officer Automatic Sell 13,586 180.83 - 183.10
Jan 2, 2013 powchik peter Officer Automatic Sell 16,414 177.82
Jan 2, 2013 powchik peter Officer Option Execute 30,000 21.25
Dec 24, 2012 schleifer leonard s Officer Disposition (Non Open Market) 59,271 n/a
Dec 20, 2012 powchik peter Officer Automatic Sell 6,623 170.44 - 171.11
Dec 20, 2012 van plew daniel p Officer Option Execute 2,050 16.80
Dec 19, 2012 mccorkle douglas s Officer Automatic Sell 1,841 174.52 - 180.75
Dec 19, 2012 powchik peter Officer Automatic Sell 10,356 176.79 - 183.13
Dec 19, 2012 yancopoulos george Officer Option Execute 50,846 9.49 - 21.92
Dec 18, 2012 aberman michael s Officer Option Execute 1,200 24.00
Showing 341-360 of 920 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)